Next generation sequencing NGS News and Research

RSS

Identifying early routes of SARS-CoV-2 introduction to Los Angeles

Researchers at Cedars-Sinai Medical Center, Los Angeles, have described for the first time, the likely sources of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) introduction to the Los Angeles community.

15 Jun 2020

Dante Labs, Cambridge Cancer Genomics and Nonacus collaborate to provide precision oncology at scale

Dante Labs, Cambridge Cancer Genomics, and Nonacus, today announced that they have signed a collaboration agreement.

15 Jun 2020

Texas A&M scientists develop 2D nanosheets to advance cancer treatment

Scientists in the Department of Biomedical Engineering at Texas A&M University are developing new ways to advance the field of regenerative medicine and cancer treatment. They are developing a 2D nanosheet that is 1,000 times smaller than a strand of hair.

10 Jun 2020

Next-generation sequencing of COVID-19 virus offers powerful metagenomic data

Next-generation sequencing of the COVID-19 virus is providing powerful metagenomic data, which, combined with clinical data, will inform the search for effective treatments, as reported in the peer-reviewed journal Pediatric Allergy, Immunology, and Pulmonology.

4 Jun 2020

Base Genomics launches and raises $11 million USD to progress development of its TAPS technology

Epigenetics company Base Genomics has launched with a team of leading scientists and clinicians to set a new gold standard in DNA methylation detection.

4 Jun 2020

Researchers identify genetic codes of COVID-19 and SARS viruses that may promote their lifecycles

Researchers have identified specific portions of the genetic codes of the COVID-19 and SARS viruses that may promote the viruses' lifecycles. The new technique is researchers' first tool for determining what genetic sequences stored as RNA - DNA's chemical cousin - are more stable.

2 Jun 2020

Pandemic presents new hurdles, and hope, for people struggling with addiction

Before Philadelphia shut down to slow the spread of the coronavirus, Ed had a routine: most mornings he would head to a nearby McDonald’s to brush his teeth, wash his face and — when he had the money — buy a cup of coffee.

2 Jun 2020

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.

29 May 2020

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

27 May 2020

New data may help understand the evolution of Austrian SARS-CoV-2 strains

216 SARS-CoV-2 genome sequences have now been completed and released in the framework of the "Mutational Dynamics of SARS-CoV-2 in Austria" project from CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna, the Medical University of Innsbruck and the Austrian Agency for Health and Food Safety (AGES).

27 May 2020

Methods to move precision medicine from evaluation into practice and policy

Value in Health, the official journal of ISPOR - the professional society for health economics and outcomes research, announced today the publication of a series of articles focused on methods for moving from the evaluation of precision medicine into practice and policy.

26 May 2020

New AI tool could predict risk of lung cancer recurrence

Computer scientists working with pathologists have trained an artificial intelligence tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment, as part of Cancer Research UK’s landmark TRACERx study.

26 May 2020

The infection of lung stem cells may determine SARS-CoV-2 pathogenicity

A group of researchers from Russia and France has demonstrated how stem cells in the lungs can be readily infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to significant defects in their regeneration capacity and more severe coronavirus disease (COVID-19). Their manuscript is currently available on the preprint server bioRxiv.

25 May 2020

New technique reveals potentially treatable mutations in subset of prostate cancer patients

Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable mutations in their DNA damage-repair genes, according to research published in the May issue of The Journal of Nuclear Medicine.

20 May 2020

ACMG: Technical standard on CFTR variant testing updated

It has been nearly two decades since the American College of Medical Genetics and Genomics, together with the American College of Obstetricians and Gynecologists, made the landmark recommendation that cystic fibrosis (CF) become the first target of pan-ethnic universal carrier screening, with ACMG identifying a core panel of 23 pathogenic variants to be tested.

14 May 2020

Study sheds more light on the evolutionary ancestry of SARS-CoV-2

There is ongoing debate among policymakers and the general public about where SARS-CoV-2, the virus that causes COVID-19, came from. While researchers consider bats the most likely natural hosts for SARS-CoV-2, the origins of the virus are still unclear.

12 May 2020

Next generation sequencing NGS News and Research

Identifying early routes of SARS-CoV-2 introduction to Los Angeles

Dante Labs, Cambridge Cancer Genomics and Nonacus collaborate to provide precision oncology at scale

Texas A&M scientists develop 2D nanosheets to advance cancer treatment

Next-generation sequencing of COVID-19 virus offers powerful metagenomic data

Base Genomics launches and raises $11 million USD to progress development of its TAPS technology

Researchers identify genetic codes of COVID-19 and SARS viruses that may promote their lifecycles

Pandemic presents new hurdles, and hope, for people struggling with addiction

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

New data may help understand the evolution of Austrian SARS-CoV-2 strains

Methods to move precision medicine from evaluation into practice and policy

New AI tool could predict risk of lung cancer recurrence

The infection of lung stem cells may determine SARS-CoV-2 pathogenicity

New technique reveals potentially treatable mutations in subset of prostate cancer patients

ACMG: Technical standard on CFTR variant testing updated

Study sheds more light on the evolutionary ancestry of SARS-CoV-2

Lab Automation for Biome Research

Study provides more insight into the initiation and progression of human cancers

ASU team identifies new, unique SARS-CoV-2 mutation

Horizon Discovery extends coverage of OncoSpan reference standards to FFPE and Liquid Biopsy

Introduction to NGS library prep miniaturization and automation eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News